VEGFB ameliorates insulin resistance in NAFLD via the PI3K/AKT signal pathway
Our studies suggest that VEGFB could present a novel strategy for treating NAFLD as a positive factor.
Authors
- Y. Li (ORCID: https://orcid.org/0000-0003-0236-8581)
- Qinyu Meng
- Meizi Yang (ORCID: https://orcid.org/0000-0002-6535-653X)
- Wenhao Li (ORCID: https://orcid.org/0000-0002-5050-443X)
- Lei Zhang (ORCID: https://orcid.org/0000-0002-4880-824X)
- Yana Li (ORCID: https://orcid.org/0000-0002-3386-9090)
- Xiaonan Zhu
- Fang Xu (ORCID: https://orcid.org/0000-0002-6021-9245)
- Nuo Xu (ORCID: https://orcid.org/0009-0000-1762-909X)
- Wen G. Jiang (ORCID: https://orcid.org/0000-0002-3283-1111)
Institutions
- Binzhou Medical University (CN)
- Shandong University of Aeronautics (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1186/s12967-024-05621-w
- Citations
- 23
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 8.89
Funders
- Natural Science Foundation of Shandong Province